MedWatch

Zealand Pharma planned for success

Despite great progress of its clinical pipeline and the initiation of two phase III studies, the Danish biotech company Zealand Pharma maintains its guidance for the level of costs in 2017. “We planned for success from the beginning of the year,” says CEO Britt Meelby Jensen.

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us free for 14 days

Try a trial subscription for free access to our quality journalism

Frontpage right now

Lægemiddelstyrelsen er skuffet, men glad for bronzen

Lægemiddelstyrelsens direktør Thomas Senderovitz er skuffet over, at København ikke skal huse EMA, men også stolt over at have snuppet "bronzemedaljerne". Han påpeger dog også, at der ligger masser af arbejde forude i forbindelse med flytningen af lægemiddelagenturet.

Latest Top picks in English

Related articles